mediLexicon, Nov. 15, 2007 Regenetech Inc. has signed a Sponsored Research Agreement with Johns Hopkins University in order to work toward a treatment for type 1 diabetes. This is in addition to the research agreements that the company has in place with UTMB and Texas A&M University. UTMB supplies blood and cord blood stem cells to Regenetech's laboratories.